About this document
FABP4 in Ovarian Cancer Metastasis by sp25-bse-091 is a document available to read on EtoBox.
The study investigates the role of adipocyte-induced FABP4 expression in ovarian cancer cells, revealing that FABP4 is crucial for lipid metabolism and contributes to metastasis and carboplatin resistance. Knockdown of FABP4 decreases cancer cell survival and metastatic burden in mouse models, while a small molecule inhibitor of FABP4 enhances sensitivity to chemotherapy. These findings suggest that targeting FABP4 may provide a novel therapeutic strategy for treating ovarian cancer metastasis.
- Author
- sp25-bse-091
- Language
- EN